|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Mindray Medical International Limited (NYSE: MR), a China-based manufacturer of patient monitoring and life support products, in-vitro diagnostic products, and medical imaging systems. |
|---|---|
| Transferring Party | Datascope Corp. (Nasdaq: DSCP), a manufacturer of proprietary products for interventional cardiology, radiology, cardiovascular, emergency medicine and critical care. |
| Sector | Medical Devices |
| Date | May 15, 2008 |
| Analysis Mindray continues its US market expansion creating the third-largest player in the global patient monitoring device industry. Deal value - $202m on sales of $161.3m (1.25x). Mindray expects ~ $30m of run-rate synergies in manufacturing, SG&A and R&D within 3 years. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |